Gilead Says Law Firm's Ads Misrepresent HIV Drug Suit

  • Home >
  • Resources >
  • Gilead Says Law Firm's Ads Misrepresent HIV Drug Suit
August 25, 2020

Gilead Sciences Inc. has asked a California federal court to admonish a plaintiff’s firm representing people who have taken the anti-HIV drug Truvada and related products, alleging that the firm's ads regarding the drug's effects are irresponsible and have harmed those who could benefit from the drug according to a report in Law 360.

Lawyers representing Gilead have asked the court to force Hilliard Martinez Gonzales LLP to admonish Hilliard Martinez for making misleading claims about the health effects of Truvada, and to prohibit the firm from running similar ads in the future.

Ads similar to those done by Hilliard Martinez Gonzales LLP can create serious health consequences for vulnerable individuals, as outlined in ILR’s 2017 research paper. Thus far, three states— Tennessee, Texas, and West Virginia—have enacted legislation to increase transparency in trial lawyer ads.

08/25/2020